NYSE: RVTYRevvity Inc Stock
$100.86+1.48 (+1.49%)
Updated Apr 19, 2024
RVTY Price
$100.86
Fair Value Price
N/A
Market Cap
$12.46B
52 Week Low
$79.50
52 Week High
$135.67
P/E
18.14x
P/B
1.58x
P/S
4.9x
PEG
0.92x
Dividend Yield
0.28%
Revenue
$2.75B
Earnings
$693.09M
Gross Margin
56%
Operating Margin
29.6%
Profit Margin
25.2%
Debt to Equity
0.72
Operating Cash Flow
$91M
Beta
0.88
Next Earnings
Apr 29, 2024
Ex-Dividend
Apr 18, 2024
Next Dividend
May 10, 2024
RVTY Overview
PerkinElmer, Inc. offers instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company serves laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer was founded in 1937 and is headquartered in Waltham, MA.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RVTY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RVTY ($100.86) is trading above its intrinsic value of $68.85, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RVTY is good value based on its earnings relative to its share price (18.14x), compared to the US market average (40.51x)
P/E vs Market Valuation
RVTY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more RVTY due diligence checks available for Premium users.
Be the first to know about important RVTY news, forecast changes, insider trades & much more!
RVTY News
Valuation
RVTY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18.14x
Industry
36.14x
Market
40.51x
RVTY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RVTY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
RVTY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.58x
Industry
4.01x
RVTY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RVTY price to earnings growth (PEG)
For valuing profitable companies with growth potential
RVTY is good value based... subscribe to Premium to read more.
PEG Value Valuation
RVTY's financial health
Profit margin
Revenue
$695.9M
Net Income
$78.6M
Profit Margin
11.3%
RVTY's Earnings (EBIT) of $814.15M... subscribe to Premium to read more.
Interest Coverage Financials
RVTY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$13.6B
Liabilities
$5.7B
Debt to equity
0.72
RVTY's short-term assets ($3.00B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RVTY's long-term liabilities ($4.24B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RVTY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RVTY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$196.6M
Investing
-$414.8M
Financing
-$19.6M
RVTY's operating cash flow ($91.27M)... subscribe to Premium to read more.
Debt Coverage Financials
RVTY vs Diagnostic & Research Stocks
Revvity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.